General Information
Revision date
2011-03-16
Product name
DAB
Product Synonyms
3,344 Biphenyltetramine, tetrahydrochloride: [1,1"-Biphenyl]-3,3.4,4"tetramine, hydrochloride (1:4); [1,1-Biphenyl]-3,3"4,4"tetramine, tetrahydrochloride; 3,3-
CAS No.
7411-49-6
1.2.1 Relevant identified uses
Refer to the instruction 800.424.9300 booklet for proper and OUTSIDE US
supplier name
Thermo Fisher Scientific
Manufacturer Name
Therma Fisher Scientific
Icons in SDS
Company Information
company name
Therma Fisher Scientific
GHS Information
Signal word
»
Section 2
SECTION 2: Hazards identification
(29 CFR 1910.1200) Emergency overview Physical state + Solid, (Crystaliine powder] Color + Pink or lavender. [Light]
Signal word
» WARNING!
Hazard statements
+ CAUSES RESPIRATORY TRACT, EYE AND SKIN IRRITATION. MAY BE HARMFUL IF SWALLOWED, POSSIBLE CANCER HAZARD - MAY CAUSE CANCER, BASED ON ANIMAL DATA.
Precautionary statements
Donot handle until all safety precautions have been read and understood, Obtain special instructions before use. Do not ingest. Avoid breathing dust. Use only with adequate ventilation. Avoid contact with eyes, skin and clothing. Keep container tightly closed. Use personal protective equipment as required, Wash thoroughly after handling. OSHAHCS status This material is considered hazardous by the
Potential Acute Health Effects
Inhalation + Irritating to respiratory system. Exposure to decomposition products may cause a health hazard, Serious effects may be delayed following exposure, 16/2011. 19 Life Science Resesrct PO Bax 117 Rocklord. IL (8151 988-0747 ww.therma.com Pierce Biotechnology Inc. 5747 N. hleridan Road 61105 (815) 968-7316 Fax DAB Ingestion : Harmful if swallowed. Skin ‘Imitating to skin.
Potential chronic health
effects Eyes Iimitating to eyes, + Repeated or prolonged inhalation of dust may lead fo chronic respiratory irritation. Carcinogenicity + May cause cancer, based on animal data, Risk of cancer depends on duration and level of exposure, Mutagenicity + No known significant effects or critical hazards,
Teratogenic Effects
+ No known significant effects or critical hazards, Developmental effects + No known significant effects or critical hazards, Fertility effects + No known significant effects or critical hazards, Over-expasure siqns/symptoms Inhalation » Adverse symptoms may include the following: respiratory tract irritation coughing Ingestion No specific data. Skin : Adverse symptoms may include the following: infitation redness Eyes : Adverse symptoms may include the following: pain or innitation watering redness Medical conditions : None known. aggravated by over- exposure See toxicological information (Section 11)
